Home › Acute Lymphoblastic Leukemia › Massachusetts › Boston

Pag-aaral pangklinika para sa Acute Lymphoblastic Leukemia sa Boston, MA

Isang pag-aaral para sa Acute Lymphoblastic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Nagre-recruit

Dana-Farber/Boston Children s Hospital, Boston

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05621291

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

DFCI/BWH Brigham and Women's Hospital, Boston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT06059391

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

Brigham and Women's Hospital, Boston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07020533

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT03104491

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

ALL Backbone in AYAs

Nagre-recruitPhase 2

Dana Farber Cancer Institute, Boston

Edad 18 hanggang 51 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07227584

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital Corporation d/b/a Boston Children's Hospital, Boston

1 Day – 17 Years · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Tufts Medical Center, Boston
Beth Israel Deaconess, Boston
Dana Farber Cancer Institute, Boston

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral

Dana-Farber Cancer Institute, Boston

Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Nagre-recruitPhase 1

Dana Farber Cancer Institute, Boston

Edad 13 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 1 hanggang 40 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT05292664

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa Acute Lymphoblastic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.